Epixone-TZ 250mg/31.25mg Injection
Marketer
Epitome Life Sciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Epixone-TZ 250mg/31.25mg Injection
Combiflox-TZ 250mg/31.25mg injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, curbing infection spread. Administration must be under a doctor's direct guidance; adherence to the prescribed schedule is crucial. Complete the full treatment course, regardless of symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Seek urgent medical help for allergic reactions such as rashes, itching, swelling, or respiratory distress. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing, avoid driving if experiencing drowsiness or dizziness. Ensure adequate rest, nutrition, and hydration to promote recovery. Your physician may order tests to monitor the medication's effects.
Uses of Epixone-TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Epixone-TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified nursing staff; self-medication is strictly prohibited.
Common Side effects of Epixone-TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Epixone-TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Epixone-TZ 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam 250mg/31.25mg (Epixone-TZ) injection combines a cephalosporin antibiotic, Ceftriaxone, with the beta-lactamase inhibitor, Tazobactam. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, compromising bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Epixone-TZ 250mg/31.25mg Injection.
PregnancySAFE IF PRESCRIBED
Injections of Epixone-TZ 250mg/31.25mg are usually deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; the available data from human trials, however, is scant.
Breast feedingCAUTION
Administering Epixone-TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
The injection Epixone-TZ (250mg/31.25mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Epixone-TZ 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Epixone-TZ 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended. Dosage alteration for Epixone-TZ 250mg/31.25mg Injection is unnecessary for those with mild to moderate liver disease.
What if you forget to take Epixone-TZ 250mg/31.25mg Injection :
Omitting a scheduled dose of Epixone-TZ 250mg/31.25mg Injection necessitates contacting your physician.
Facts to Know About Epixone-TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobials |
3,018 People bought this recently